Downer EDI confirms growth expectations

Our Algo Engine generated a buy signal in Downer EDI back in June at $6.60, with the stock price now pushing $8.00, most of the good news is priced in.

The FY18 earnings were announced on Thursday and the numbers were in line with consensus expectations. The highlight is the forward guidance of 13% growth.

FY18 NPATA came in at $296 & FY19 guidance now sits at $335m. This places Downer EDI on a forward yield of 4%.

Buy Healthscope

Healthscope report earnings on Tuesday and the market is looking for NPAT to increase to $170m. We’re expecting the FY19 outlook statement to support the share price.

Technically, HSO has now filled the price gap to $2.08

 

Australian Banks & Credit Quality

We continue to watch the lower high formations in the Australian bank names and expect the current rally to soon run into Resistance.

Low revenue growth, restructuring costs, and reduced product and regional footprint will cap earnings. We’re also watching credit quality data across credit cards, motor vehicle sales and home loans.

Trends within the Australian residential mortgage 90+ day past due loans, as a percentage of residential mortgage exposure-at-default, was mostly flat from the prior quarter. NAB’s Pillar 3 release shows only a slight uptick, whereas CBA’s result last week showed a greater increase in home loan 90+ day arrears.

There are some pockets of stress in the mortgage books, primarily in WA.

ETF covering Australian banks shows a retest of the recent highs.

Where as the ETF covering global banks shows a pronounced lower high formation.